Is Vilon safe?
Limited EvidenceSide effects, risks, and safety considerations based on available research.
Research status
Vilon has very limited human safety data. Most information comes from animal studies, in vitro research, or anecdotal reports. This means the true risk profile in humans is largely unknown.
Known concerns & side effects
- ⚠evidence exclusively from Khavinson research group — no independent replication
- ⚠clinical trial quality below modern RCT standards
- ⚠dipeptide Lys-Glu not established as pharmacologically active in mainstream biology
- ⚠as a dietary supplement, the same dipeptide sequence appears naturally in many food proteins — specific bioregulator effect at physiological doses unestablished
Use caution with
See all 1 studies on the full Vilon profile.
Frequently asked questions
Is Vilon better than Thymalin since it is simpler?
They target somewhat different purposes in the Khavinson system — Thymalin is a complex thymic extract targeting T-cell renewal, while Vilon (KE dipeptide) has broader claimed immune-modulating effects. Vilon's main advantage is its simplicity: more stable, potentially orally bioavailable, and better characterized chemically than the full thymus polypeptide complex. Neither has strong evidence by modern Western standards.
Full Vilon Profile
Evidence, timeline, products & more
Take the Peptide Quiz
Get personalized recommendations
Last updated: 2026-06-10
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.